Definitive Contract W81XWH19C0171
Award Date 8/26/19
Potential Completion Date 10/25/23
Potential Value $1.1M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Winston-Salem, NC 27101, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- The Department of the Army Medical Command awarded Keranetics Inc., doing business as Keranetics, a $699,139.77 firm fixed price contract to support research and development efforts under Phase II of the Small Business Innovation Research program. The contract aims to advance Keranetics' KeraStat(R) gel technology to prevent scar contracture after burn injuries, as proposed in their submission titled "KeraStat(R) Gel to Prevent Scar Contracture After Burn Injuries." The prime...
- This is a $973,434.89 definitive contract awarded by the Department of the Army Medical Command to Keranetics Inc., a small business, under the SBIR Program Phase II. The contract is for the development of technology to address the complex architecture of the face during the treatment of severe facial burn injury. Keranetics, a for-profit organization that provides medical research and development services, will perform the work in Winston-Salem, North Carolina. This award is related to the...
- The Department of the Army Medical Command awarded a $3.111 million definitive contract to Kericure Inc. on September 25, 2023, for clinical validation of a portable, ruggedized antimicrobial wound dressing in the management of large surface area burns for prolonged field care and long-term care, under a total small business set-aside. Kericure Inc. is a women-owned small business. This is a Phase III SBIR award with firm fixed pricing and an ultimate completion date of January 24, 2027. Place...
- This is a $999,998.87 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Keranetics, LLC, a for-profit limited liability company. The contract was awarded on September 1, 2015 and has an ultimate completion date of January 31, 2021. The award is for the DHP SIBR SECOND PHASE II effort under SBIR Topic #OSD10-H03. The contract is a definitive contract with a cost-no-fee pricing type. Keranetics has prior experience as a federal grant prime...
- The Department of the Army Medical Command awarded Kericure Inc.'s Kericure Medical Division a $2.2 million firm fixed price contract under the Small Business Innovation Research Program Phase II solicitation for deployable wound care products. The contract aims to decrease preventable death outcomes by mitigating infection on the battlefield and through long-term care. As a Phase II SBIR award from the Army, the contract builds upon prior research and development efforts to further mature...
- The Defense Health Agency awarded a $1.299 million definitive contract to Kericure Inc. for development of deployable wound care products to decrease preventable death outcomes by mitigating infection on battlefield and long-term care settings, under a total small business set-aside, on September 22, 2023. Kericure Inc., a women-owned small business, will perform work at Wesley Chapel, FL. This is a Phase II SBIR award with firm fixed pricing and an ultimate completion date of April 21, 2027....
- The Department of the Army Medical Command awarded a $549,725 firm fixed price Small Business Innovation Research Program Phase III follow-on medical research and development contract to Synedgen, Inc. for the development of technologies that control scar formation after burn injuries. As the prime contractor, Synedgen will leverage its expertise in regenerative medicine and wound healing to advance scientific knowledge and technologies aimed at reducing scarring and improving outcomes for...
- This is a $2,994,281.25 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Paranano Wound Care LLC, a small business, under the SBIR (Small Business Innovation Research) program. The contract is for Phase II of a project titled "The BIOZ Smart Bandage Empowering Priority Response to Pathogen Invasion in Wounds" and has an ultimate completion date of July 11, 2027. The contract is focused on medical research and development related to wound care and pathogen...
- This is a U.S. Army SBIR (Small Business Innovation Research) Phase II contract awarded to Silk Technologies, Ltd., a for-profit manufacturer, in the amount of $1,536,825.77. The contract was set aside for small businesses and was awarded by the Department of the Army Medical Command. The contract is for STTR (Small Business Technology Transfer) Phase III research, which typically involves the commercialization of technologies developed under previous SBIR/STTR phases. The work will be performed...
- <p>The Department of the Army Medical Command awarded a $2,195,569.75 definitive contract to Ifyber LLC for research and development of standard-issue antimicrobial combat burn gauze on September 21, 2020, under a total small business set-aside.</p> <p>This is a Phase II Small Business Innovation Research award for proposal H2D-0027. Work is performed in Ithaca, NY under firm fixed price terms. The ultimate completion date is June 30, 2025.</p>
This is a $1,070,532.90 firm fixed-price SBIR Phase II research and development contract awarded by the U.S. Army Medical Command (MEDCOM) to Keranetics Inc., a small business based in Winston-Salem, North Carolina. The contract is for the "Clinical Evaluation of Biocompatible Dressings for the Delivery of Analgesics" and was awarded under solicitation H2-0480. Keranetics is developing its KeraStat gel technology to prevent scar contracture after burn injuries. This SBIR Phase II contract will support preclinical, regulatory, and manufacturing development activities for Keranetics' biocompatible wound dressing product. The contract has a period of performance through October 25, 2023.
Generated 4/23/25, 12:04 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Supplemental Agreement for work within scope | $0 | 1/24/23 | |
| P00004 | Other Administrative Action | $0 | 8/17/21 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 10/19/20 | |
| P00002 | Other Administrative Action | $0 | 1/23/20 | |
| P00001 | Other Administrative Action | $0 | 10/2/19 |